Centinel Spine launched the Patient Access Program, designed to further expand patient access to the prodisc® L Lumbar Total Disc Replacement (TDR). The program will focus on providing reimbursement support for two-level lumbar disc replacement procedures using prodisc L, the only lumbar TDR product that is FDA-approved for two-level use.
The Patient Access Program was developed with and will be administered in conjunction with Musculoskeletal Clinical Regulatory Advisors, a healthcare industry advisory firm.
“The Patient Access Program is here to provide patients the benefit of covered access to a motion preserving technology clinically proven over the last 30 years,” stated Centinel Spine CEO Steve Murray. “We have been encouraged by the continued progress in expanded coverage for single-level lumbar TDR procedures, and continue work to advance these same coverage benefits for patients with two-level disc disease,” Murray concluded.
Centinel Spine remains the only company with FDA-approved cervical and lumbar total disc replacement devices.
Centinel Spine launched the Patient Access Program, designed to further expand patient access to the prodisc® L Lumbar Total Disc Replacement (TDR). The program will focus on providing reimbursement support for two-level lumbar disc replacement procedures using prodisc L, the only lumbar TDR product that is FDA-approved for two-level...
Centinel Spine launched the Patient Access Program, designed to further expand patient access to the prodisc® L Lumbar Total Disc Replacement (TDR). The program will focus on providing reimbursement support for two-level lumbar disc replacement procedures using prodisc L, the only lumbar TDR product that is FDA-approved for two-level use.
The Patient Access Program was developed with and will be administered in conjunction with Musculoskeletal Clinical Regulatory Advisors, a healthcare industry advisory firm.
“The Patient Access Program is here to provide patients the benefit of covered access to a motion preserving technology clinically proven over the last 30 years,” stated Centinel Spine CEO Steve Murray. “We have been encouraged by the continued progress in expanded coverage for single-level lumbar TDR procedures, and continue work to advance these same coverage benefits for patients with two-level disc disease,” Murray concluded.
Centinel Spine remains the only company with FDA-approved cervical and lumbar total disc replacement devices.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
